Antidiabetic treatment, stroke severity and outcome

doi:10.4239/wjd.v5.i2.84

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6168)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-1) series.

Item

Count

PDF

690

WORD

227

HTML

2835

Tables (1-1)

266

Sum=4018

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1100

Download

1050

Sum=2150

Apr 15, 2014 (publication date) through Jan 10, 2025

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Field Of Vision

World J Diabetes. Apr 15, 2014; 5(2): 84-88
Published online Apr 15, 2014. doi: 10.4239/wjd.v5.i2.84

Antidiabetic treatment, stroke severity and outcome

Dimitra Magkou, Konstantinos Tziomalos

Dimitra Magkou, Konstantinos Tziomalos, First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki 54636, Greece

Author contributions: Magkou D drafted the paper; Tziomalos K revised the draft critically for important intellectual content.

Correspondence to: Konstantinos Tziomalos, MD, PhD, First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 1 St. Kyriakidi, Thessaloniki 54636, Greece. ktziomalos@yahoo.com

Telephone: +30-2310-994621 Fax: +30-2310-994773

Received: September 4, 2013
Revised: November 2, 2013
Accepted: January 6, 2014
Published online: April 15, 2014
Processing time: 226 Days and 8.6 Hours

Core Tip

Core tip: A recent study showed reduced stroke size following pretreatment with linagliptin, a dipeptidyl peptidase-4 (DDP-4) inhibitor, compared with glimepiride, in both diabetic and non-diabetic mice. It remains to be shown whether these neuroprotective actions of DPP-4 inhibitors will also be observed in humans.